ArticleSmall science2026
Integration of NanoMIPs With Gold-Patterned Plasmonic Surfaces as Synthetic Protein A.
Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In modern bioanalytical sensing, the integration of biorecognition elements with transducer platforms represents an established strategy for achieving selective detection. Among the available bioreceptors, proteins have been widely used for their ability to mediate highly specific interactions. However, proteins often present limitations such as instability, high production costs, animal-derived manufacturing, and strict storage protocols. A promising alternative is molecularly imprinted polymeric nanoparticles (nanoMIPs), which have shown potential due to features such as greater stability, durability, and potentially lower costs. This study introduces, for the first time, the use of nanoMIPs imprinted for IgG on a silicon surface functionalised with gold nanoparticles. These nanoMIPs are designed to bind IgG in an oriented manner by targeting Fc-specific epitopes selected through a novel epitope-mapping technique. Detection is based on metal-enhanced fluorescence (MEF), which significantly amplifies the signal. The sensor showed high specificity for IgG, with no cross-reactivity toward IgA, reaching a detection limit of 10 ng mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.